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INTRODUCTION 
Diabetes mellitus is affecting the people in epidemic 
proportion. Emphysematous pyelonephritis (EPN) is a 
very rare life threatening infection of the kidneys with 
characteristic gas formation in the renal parenchyma or 
perirenal tissues [1 - 4]. It is commonly seen in patients 
of uncontrolled diabetes mellitus with bilateral renal 
involvement [5}. E coli is the most common causative 
organism in 70% cases [4].  Computed tomography 
scan (CT) is the most sensitive investigation (100%) to 
confirm the diagnosis. EPN may present with nonspe-
cific symptoms like abdominal pain, fever, nausea, 
vomiting with sudden clinical deterioration. Treatment 
includes antibiotics, nephrostomy and nephrectomy 
[1,4]. It carries high mortality of 60-75% with antibiotics 
alone and 21-29 % with antibiotics and nephrectomy 
[6].  
CASE REPORT 
We report a case of 60 year old female, a known dia-
betic since 3 years and on oral hypoglycaemic agents. 
Her blood sugar levels were not controlled. She com-
plained of high grade fever 102o F with rigors and 
chills, pain right lower abdomen, vomiting and dysuria 
since 7 days. There was no history of diarrhoea and 
jaundice. On examination her vitals were BP 120/80 
mmHg, Pulse rate 80 beats/min regular and respiratory 
rate 20/min. abdominal examination revealed tender-
ness in right lower abdomen without hepato-
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splenomegaly. Cardiovascular, respiratory and nervous 
system examination revealed no abnormality. 
Laboratory investigations on admission revealed hemo-
globin 10.2 g/dl; Total leucocyte count 17200/mm3, 
Differential cell count P:80, L:20, E:0, B: 0, Blood urea 
70 mg/dl, Serum creatinine 1.9 mg/dl, Fasting blood 
glucose 190 mg/dl, HBA1c 8.2%, ESR 25 mm at the end 
of first hour. ECG was showing tachycardia. X-ray chest 
and 2D Echocardiography was normal. Urine examina-
tion showed sugar 2+ along with plenty of pus cells. 
Urine examination was sent for culture and sensitivity. 
Ketone bodies were negative. Liver, lipid and electro-
lytes profile were normal. 
Ultrasound abdomen revealed presence of gas in the 
right kidney suggestive of EPN (Figure 1) which was 
confirmed by CT scan abdomen (Figure 2).  
 
 
Figure 1. USG abdomen demonstrating gas accumula-
tion in right kidney parenchyma. 
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Figure 2. Contrast CT demonstrating gas accumulation 
limited to the right kidney parenchyma 
 
Based on clinical symptomatology and radiological find-
ings, a diagnosis of EPN was made, so the patient was 
started on normal saline, subcutaneous short acting 
insulin, inj ceftriaxone. In the meantime urine culture 
report showed growth of E Coli sensitive to mero-
penem. We switched to parenteral merpenam 1 gm/
twice daily and metronidazole 500mg/thrice daily 
which were continued for 2 weeks. There was marked 
clinical improvement with resolution of symptoms. She 
was discharged on short acting insulin along with 
ciprofloxacin. She did not need nephrostomy/ nephrec-
tomy. Her CT scan abdomen reported at 1 month inter-
val was normal. 
 
DISCUSSION 
 
EPN is an acute and chronic necrotizing pyelonephritis 
characterized by gas formation within renal parenchy-
ma or perirenal tissues. It was first described by Kelly 
and McCallum with greater incidence in females over 
males. Predisposing factors include uncontrolled diabe-
tes mellitus, acidosis, impaired immune mechanisms, 
dehydration, electrolyte disturbance, urinary calculi, 
calyceal stenosis etc. Infecting organisms usually con-
sist of mixed flora including E.coli (70 % cases), Klebsiel-
la pneumonia, Proteus mirabilis, Pseudomonas aeru-
ginosa, Enterobacter and candida [4,7,8]. These are 
fermenting organisms, which provide hydrogen, oxy-
gen, nitrogen, and carbon dioxide [9].  
Common clinical features include fever, abdominal 
pain, dysuria, disorientation, confusion and septicae-
mia[1]. Our patent presented with hyperglycaemia, 
fever, dysuria, pain right lower abdomen and pyuria 
suggestive of pyelonephritis. However plain X-ray abdo-
men, U/S and CT abdomen revealed presence of gas in 
renal parenchyma thus confirming the diagnosis of 
EPN.  
Ultrasound and CT abdomen is the main investigation 
for diagnosis and treatment [1,4,10]. According to CT, 
EPN is classified into 4 types depending upon anatomi-
cal location of gas [1,10]. Type I is characterized by gas 
confined to collecting system; Type II  gas  confined to 
renal parenchyma; Type III a gas extending to perineph-
ric region; Type III b gas extending beyond Gerota fas-
cia while Type IV characterized by bilateral EPN. Our 
patient was in class 2,conservative treatment started 
with iv fluids, sugar monitoring and  responded well to 
meropenem and metronidazole given for 2 weeks and 
recovered completely without need for nephrostomy/
nephrectomy. 
Good hydration, fluid resuscitation, and treatment with 
systemic antibiotics are the first line management in 
EPN. A monitored-care facility may be needed for pa-
tients in shock. Control of diabetes and maintenance of 
adequate fluid balance should be achieved quickly. No 
contraindications exist for the treatment of EPN. The 
infection often has a fulminating course and can be 
fatal if left untreated. However, surgical intervention 
should be performed only after stabilization of the pa-
tient’s cardiorespiratory status 
EPN is medical emergency, must be treated with ag-
gressive medical management and, possibly, surgical 
intervention [11] to reduce mortality. 
Conservative treatment using percutaneous drainage 
with antibiotics is indicated in following conditions: 
[12,13] 
 Patients with compromised renal function. 
 Early cases associated with gas in the collecting sys-
tem alone and patient is in otherwise in stable con-
dition. 
 Class 1 and class 2 EPN. 
 Class 3 and class 4 EPN - In the presence of fewer 
than 2 risk factors (eg, thrombocytopenia, elevated 
serum creatinine levels, altered sensorium, shock). 
The use of nephrectomy is indicated as follows [14] 
 Treatment of choice for most patients. 
 No access to percutaneous drainage or internal 
stenting (after patient is stabilized). 
 Gas in the renal parenchyma or "dry-type" EPN. 
 Possibly bilateral nephrectomy in patients with bi-
lateral EPN. 
 Class 3 and class 4 EPN - In the presence of more 
than 2 risk factors (eg, thrombocytopenia, elevated 
serum creatinine, altered sensorium, shock). 
Lu et al recommend tailoring initial therapy according 
to the classification system of Huang and Tseng and risk 
factors for resistance, as follows[8}: 
 Class 1: A third-generation cephalosporin, with or 
without amikacin, plus percutaneous catheter drain-
age in patients with obstructive uropathy 
 Class 2, 3, and 4: without risk factors – A third-
generation cephalosporin, with or without amikacin, 
plus percutaneous catheter drainage 
 Class 2, 3, and 4: with risk factors – Carbapenem 
with or without vancomycin plus percutaneous 
catheter drainage 
CONCLUSION 
 
Emphysematous pyelonephritis (EPN) is a severe, ne-
crotizing renal parenchymal infection that is character-
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ized by the production of intraparenchymal gas. EPN 
predominantly affects female diabetics, and can occur 
in insulin-dependent and non-insulin-dependent pa-
tients in the absence of ureteric obstruction. Non-
diabetic patients can also develop EPN, but often have 
ureteric obstruction and do not seem to develop such 
extensive disease. 
EPN should be suspected in a diabetic patient with un-
controlled diabetes, pyuria, abdominal pain, fever, 
vomiting not responding to appropriate antibiotics. It is 
a life threatening fatal condition which requires early 
diagnosis and prompt use of higher antibodies along 
with control of diabetes in order to prevent complica-
tions and reduce mortality 
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